P4HB and esophageal squamous cell carcinoma: Additionally, treatment with a P4HB inhibitor, CCF642, inhibited myoblast apoptosis in vitro, and ameliorated body weight loss and muscle wasting in vivo, which provides a novel strategy in treatment of ESCC‐associated cachexia.